Over the last decade, CRISPR Therapeutics has built deep R&D capabilities, entered strategic collaborations, and established a manufacturing footprint to advance the deployment of transformative gene-based therapies.

Fed Chair Powell's Jackson Hole speech hinted at potential policy adjustments as economic conditions evolve, with markets rallying on his balanced approach.